Show Notes
What if the key to curing disease like Alzheimer’s lies in the tiny, invisible molecules inside our cells?
In this episode of Holy Shift!: Biomedical Breakthroughs Shaping Tomorrow, host Angela Gill Nelms sits down with Dr. Felipe Quiroz, Assistant Professor of Biomedical Engineering at Georgia Tech and Emory University. Dr. Quiroz reveals how his lab engineers the invisible — proteins, cells, and genes — to understand and treat diseases like Alzheimer’s. From discovering how disordered proteins shape brain health to inspiring the next generation of scientists, Dr. Quiroz shares how foundational research today builds the breakthroughs of tomorrow that can transform healthcare for generations to come.
Tune in for a conversation that connects molecular science, mentorship, and hope for the future of medicine.
More from Holy Shift! Biomedical Breakthroughs Shaping Tomorrow
How do you fix the most complex machine in the known universe?
Can we train the immune system to fight cancer and stay stronger as we age?
What if the next breakthrough medicine wasn't made in a factory, but inside your own body?
In this special Season 1 roundup of Holy Shift!, host Angela Gill Nelms revisits standout moments from this season's conversations with researchers at Georgia Tech and Emory University. Guests share their engineering solutions, the personal stories and unexpected paths that brought them to the lab, and why public funding for basic science and biomedical innovation is more critical than ever. This episode features clips from conversations with Melissa Kemp, Lena Ting, David Myers, Mike Davis, Scott Hollister, Zachary Danziger, Annabelle Singer, Shella Keilholz, Machelle Pardue, Anant Madhabushi, Chethan Pandarinath, Felipe Quiroz, and Ming Fong. As we look ahead to Season 2, we want to hear from you! Take a few minutes to fill out our listener survey and let us know what you loved, what you want more of, and what we can do better. One lucky respondent will receive a Holy Shift! listener swag package.
What if we could simulate your cancer on a computer and predict which treatment will work before you ever receive it?